Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 1, 2012, Pages 21-28

  Emslie, Graham J ^a   Kennard, Betsy D ^a   Mayes, Taryn L ^a   Nakonezny, Paul A ^a   Zhu, Lian ^a   Tao, Rongrong ^a   Hughes, Carroll ^a   Croarkin, Paul ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PHYSICAL DISEASE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCHOOL CHILD; SCORING SYSTEM; SLEEP; SUICIDAL IDEATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUICIDAL IDEATION; TREATMENT OUTCOME;

EID: 84857329009     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0096     Document Type: Article

References (43)

1. Agargun MY, Kara H, Solmaz M: Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 58:249-251, 1997. (Pubitemid 27318559)
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Revised. (DSM-III-R). Washington, DC: American Psychiatric Association; 1987.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: Ameri-can Psychiatric Association; 1994.
4. Ancoli-Israel S, Krystal AD, Mc Call WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T: A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep 33:225-234, 2010.
5. Armitage R, Hoffmann R, Emslie G, Rintelman J, Moore J, Lewis K: Rest-activity cycles in childhood and adolescent depression. J Am Acad Child Adolesc Psychiatry 43:761-769, 2004. (Pubitemid 38858648)
6. Armitage R, Hoffmann RF, Emslie GJ, Weinberg WA, Mayes TL, Rush AJ: Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression. Int J Neuropsycho-pharmacol 5:217-228, 2002.
7. Birmaher B, Brent D, Bernet W, Bukstein O, Walter H, Benson R, Chrisman A, Farchione T, Greenhill L, Hamilton J, Keable H, Kinlan J, Schoettle U, Stock S, Ptakowski K, Medicus J: Practice parameter for the assessment and treatment of children and ado-lescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:1503-1526, 2007.
8. Buysse DJ, Reynolds CF, 3rd, Kupfer DJ, Thorpy MJ, Bixler E, Kales A, Manfredi R, Vgontzas A, Stepanski E, Roth T, Hauri P, Stapf D: Effects of diagnosis on treatment recommendations in chronic insomnia\-a report from the APA/NIMH DSM-IV field trial. Sleep 20:542-552, 1997. (Pubitemid 27415477)
9. Costello JE, Erkanli A, Angold A: Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 47:1263-1271, 2006. (Pubitemid 44824722)
10. Emslie GJ, Armitage R, Weinberg WA, Rush AJ, Mayes TL, Hoff-mann RF: Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder. Int J Neuropsychopharmacol 4:159-168, 2001. (Pubitemid 32587384)
11. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002. (Pubitemid 38338040)
12. Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW: Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 165:459-467, 2008. (Pubitemid 351694289)
13. Emslie GJ, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, Asarnow JR, Spirito A, Birmaher B, Ryan N, Kennard B, De Bar L, Mc Cracken J, Strober M, Onorato M, Zelazny J, Keller M, Iyengar S, Brent D: Treatment of resistant depression in adolescents (TORDIA): Week 24 outcomes. Am J Psychiatry167:782- 791, 2010.
14. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with de-pression. Arch Gen Psychiatry 54:1031-1037, 1997. (Pubitemid 27476099)
15. Emslie GJ, Rush AJ, Weinberg WA, Rintelmann JW, Roffwarg HP: Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry 47:119-124, 1990. (Pubitemid 20058086)
16. Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T: Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 29:222-230, 2009.
17. Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T: Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: A randomized controlled trial. J Clin Psychiatry 72:914-928, 2011a.
18. Fava M, Mc Call WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 59:1052-1060, 2006. (Pubitemid 43849658)
19. Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC: A post hoc analysis of the effect of nightly ad-ministration of eszopiclone and a selective serotonin reuptake in-hibitor in patients with insomnia and anxious depression. J Clin Psychiatry 72:473-479, 2011b.
20. Fawcett J, Scheftner WA, Fogg L, Clark DC, Young MA, Hedeker D, Gibbons R: Time-related predictors of suicide in major affective disorder. Am J Psychiatry 147:1189-1194, 1990. (Pubitemid 20275373)
21. Goldstein TR, Bridge JA, Brent DA: Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol 76:84-91, 2008. (Pubitemid 351215332)
22. Gould M, King R, Greenwald S, Fisher P, Schwab-Stone M, Kramer R, Flisher A, Goodman S, Canino G, Shaffer D: Psychopathology as-sociated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry 37:915-923, 1998. (Pubitemid 28406738)
23. Guy W: ECDEU Assessment Manual for Psychopharmacology. Wa-shington D.C.: US Government Printing Office; 1976. DHEW Publication ABM 76-388.
24. Ivanenko A, Barnes ME, Crabtree VM, Gozal D: Psychiatric symp-toms in children with insomnia referred to a pediatric sleep medi-cine center. Sleep Med 5:253-259, 2004. (Pubitemid 38684219)
25. Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J: Remission and residual symptoms after short-term treatment in the treatment of adolescents with de-pression study (TADS). J Am Acad Child Adolesc Psychiatry 45:1404-1411, 2006. (Pubitemid 44900913)
26. Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J: Re-mission and recovery in the treatment for adolescents with de-pression study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 48:186-195, 2009.
27. Kenward MG, Roger JH: Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983-997, 1997. (Pubitemid 27391027)
28. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P: Major depression in community adolescents: Age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33:809-818, 1994. (Pubitemid 24196904)
29. Lewinsohn PM, Rohde P, Seeley JR: Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implica-tions. Clin Psychol Rev 18:765-794, 1998. (Pubitemid 28512549)
30. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Mc Nulty S, Vitiello B, Severe J: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA 292:807-820, 2004. (Pubitemid 39079667)
31. Mayes TL, Tao R, Rintelmann JW, Carmody T, Hughes CW, Kennard BD, Stewart SM, Emslie GJ: Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine? CNS Spectr 12:147-154, 2007.
32. Mc Call WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T: A polysomnography study of eszopiclone in elderly patients with insomnia. Curr Med Res Opin 22:1633-1642, 2006. (Pubitemid 44449218)
33. Measelle JR, Stice E, Hogansen JM: Developmental trajectories of co-occurring depressive, eating, antisocial, and substance abuse problems in female adolescents. J Abnorm Psychol 115:524-538, 2006. (Pubitemid 44763682)
34. Measelle JR, Stice E, Springer DW: A prospective test of the negative affect model of substance abuse: Moderating effects of social support. Psychol Addict Behav 20:225-233, 2006. (Pubitemid 44386421)
35. O'Brien EM, Chelminski I, Young D, Dalrymple K, Hrabosky J, Zimmerman M: Severe insomnia is associated with more severe presentation and greater functional deficits in depression. J Psy-chiatr Res 45:1101-1105, 2011.
36. Ohayon M, Roth T: Place of chronic insomnia in the course of de-pressive and anxiety disorders. J Psychiatr Res 37:9-15, 2003. (Pubitemid 35449766)
37. Pollack M, Kinrys G, Krystal A, Mc Call WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R: Eszopiclone coadminis-tered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 65:551-562, 2008. (Pubitemid 351645051)
38. Poznanski EO, Mokros HB: Children's Depression Rating Scale Re-vised (CDRS-R) manual. Los Angeles: Western Psychological Services, 1996.
39. Sunderajan P, Gaynes BN, Wisniewski SR, Miyahara S, Fava M, Akingbala F, De Veaugh-Geiss J, Rush AJ, Trivedi MH: Insomnia in patients with depression: a STAR*D report. CNS Spectr 15:394404, 2010.
40. Tao R, Emslie G, Mayes T, Nakonezny P, Kennard B, Hughes C: Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry 48:71-78, 2009.
41. Tao R, Emslie GJ, Mayes TL, Nakonezny PA, Kennard BD: Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder. J Child Adolesc Psychopharmacol 20:423-430, 2010.
42. Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E: Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry 41:964973, 1997.
43. Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, De Bar L, Lynch F, Dickerson J, Strober M, Suddath R, Mc Cracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA: Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry 72:388-396, 2011.